Correlation Between RespireRx Pharmaceuticals and Cingulate Warrants

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RespireRx Pharmaceuticals and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RespireRx Pharmaceuticals and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RespireRx Pharmaceuticals and Cingulate Warrants, you can compare the effects of market volatilities on RespireRx Pharmaceuticals and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RespireRx Pharmaceuticals with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of RespireRx Pharmaceuticals and Cingulate Warrants.

Diversification Opportunities for RespireRx Pharmaceuticals and Cingulate Warrants

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between RespireRx and Cingulate is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding RespireRx Pharmaceuticals and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and RespireRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RespireRx Pharmaceuticals are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of RespireRx Pharmaceuticals i.e., RespireRx Pharmaceuticals and Cingulate Warrants go up and down completely randomly.

Pair Corralation between RespireRx Pharmaceuticals and Cingulate Warrants

If you would invest  6.00  in Cingulate Warrants on December 22, 2024 and sell it today you would lose (1.38) from holding Cingulate Warrants or give up 23.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

RespireRx Pharmaceuticals  vs.  Cingulate Warrants

 Performance 
       Timeline  
RespireRx Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days RespireRx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, RespireRx Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Cingulate Warrants 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

RespireRx Pharmaceuticals and Cingulate Warrants Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RespireRx Pharmaceuticals and Cingulate Warrants

The main advantage of trading using opposite RespireRx Pharmaceuticals and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RespireRx Pharmaceuticals position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.
The idea behind RespireRx Pharmaceuticals and Cingulate Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk